Dr. Andrea L. Cheng-Hakimian, MD

Dr. Cheng-Hakimian practices at UW Medical Center - Montlake in Seattle, Washington, part of University of Washington.

Dr. Cheng-Hakimian's NPI, 1124240254, was assigned on May 2, 2007. Dr. Cheng-Hakimian graduated from WashU Medicine in 1999. Dr. Cheng-Hakimian holds Washington license MD00043548.

Dr. Cheng-Hakimian's primary practice is UW Medical Center - Montlake, at 1959 NE Pacific St Box 356151, Seattle, WA 98195 in King County. The practice phone is (206) 598-3300.

Dr. Cheng-Hakimian's primary practice is UW Medical Center - Montlake in Seattle, Washington, part of University of Washington. Dr. Cheng-Hakimian is also affiliated with Harborview Medical Center. The medical group on file is UW Physicians. Dmand AI also links Dr. Cheng-Hakimian to 1 more hospital, 1 hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cheng-Hakimian practices, 4 sites in all. Vendor and product names are available with a free account.

Epilepsy is Dr. Cheng-Hakimian's primary specialty in the NPI Registry, under taxonomy code 2084E0001X. Dr. Cheng-Hakimian is board certified in clinical neurophysiology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Cheng-Hakimian's licenses on file in 2 states: Washington and Missouri.

Dmand AI lists epilepsy and migraine and chronic headache among the conditions Dr. Cheng-Hakimian treats.

CMS data shows 354 Medicare services from Dr. Cheng-Hakimian across 8 procedure codes in 2024, for 151 Medicare patients. Medicare paid $21,076 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 151 Medicare patients who saw Dr. Cheng-Hakimian in 2024. The largest group is 65 to 74, with 66 patients. 68% of them have high blood pressure, and 55% have high cholesterol. 33% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cheng-Hakimian's median patient age at 38, with 67% women.

In 2024, Dr. Cheng-Hakimian wrote 724 Medicare Part D claims for 51 patients. 88% of them were for generic drugs. CMS names the drug for 616 of them, across 16 drugs with 11 or more claims each, at $48,860 in total drug cost. In 2023, CMS named 607 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Cheng-Hakimian for performance year 2024, reported through an alternative payment model (APM). Dr. Cheng-Hakimian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cheng-Hakimian as offering telehealth.

Dmand AI links 6 papers to Dr. Cheng-Hakimian in 2022. The most frequent topics are Diagnosis, Differential, Electroencephalography and Epilepsy. Dr. Cheng-Hakimian has published most often in Am J Electroneurodiagnostic Technol.

Dr. Cheng-Hakimian graduated from WashU Medicine in 1999. Dr. Cheng-Hakimian is a member of AAN.

Dr. Cheng-Hakimian is in network with 18 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.